Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.
Peter K. H. Lau, S.J. Harris, Melissa Eastgate, Damien Kee, Andrew Mant, Louise M. Nott, Craig Gedye, Andrisha Jade Inderjeeth, Craig Underhill, Alison M. Weppler, Roslyn Wallace, Belinda Lee, George Au‐Yeung, Narelle Williams, Daniel Ariza Ospino, Louise Gonzales, Mark Shackleton, Serigne Lo, Grant A. McArthur, Shahneen Sandhu (2023). CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.. , 41(16_suppl), DOI: https://doi.org/10.1200/jco.2023.41.16_suppl.9525.
Article312 days agoi-Move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol
Amelia Hyatt, Karla Gough, Andrew Murnane, George Au‐Yeung, Tamara Dawson, Elizabeth Pearson, Haryana M. Dhillon, Shahneen Sandhu, Narelle Williams, Elizabeth Paton, Alex Billett, Anya Traill, Hayley Andersen, Victoria Beedle, Donna Milne (2020). i-Move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol. , 10(2), DOI: https://doi.org/10.1136/bmjopen-2019-036059.
Article312 days agoi-Move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol
Amelia Hyatt, Karla Gough, Andrew Murnane, George Au‐Yeung, Tamara Dawson, Elizabeth Pearson, Haryana M. Dhillon, Shahneen Sandhu, Narelle Williams, Elizabeth Paton, Alex Billett, Anya Traill, Hayley Andersen, Victoria Beedle, Donna Milne (2020). i-Move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol. , 10(2), DOI: https://doi.org/10.1136/bmjopen-2019-036059.
Article312 days agoAustralasian merkel cell carcinoma interest group (AMIGOs) - Improving the outlook for patients with Merkel cell carcinoma
Gerald B. Fogarty, Elizabeth Paton, Narelle Williams, Mark Shackleton, Jonathan H. Pincus, Shahneen Sandhu, Wen Xu (2019). Australasian merkel cell carcinoma interest group (AMIGOs) - Improving the outlook for patients with Merkel cell carcinoma. , 15
Article312 days agoCombination of avelumabwith peptide receptor radionuclide therapy (PRRT) or conventional fractionated radiotherapy (RT) in metastatic merkel cell carcinoma (mMCC) [GoTHAM study]
Shahneen Sandhu, Richard W. Tothill, Richard A. Scolyer, Alexander Guminski, Juergen C. Becker, Michael Poulsen, Victoria Atkinson, Paul J. Neeson, Mark Shackleton, David A. Pattison, Narelle Williams, Elizabeth Paton (2019). Combination of avelumabwith peptide receptor radionuclide therapy (PRRT) or conventional fractionated radiotherapy (RT) in metastatic merkel cell carcinoma (mMCC) [GoTHAM study]. , 15
Article312 days ago